related documents
- Benralizumab continues to improve quality of life after 6 months of treatment in Canadians with severe eosinophilic asthma Conferences
- Reduction in work and activity impairment within 6 months of benralizumab initiation in Canadians with severe eosinophilic asthma Conferences
- Sustained improvement of asthma control over 6 months of benralizumab treatment in Canadians with severe asthma Conferences